Mandate

Vinge has advised Marginalen Bank regarding a substitution of issuer for its existing capital notes and the issuance of new capital notes

June 03, 2025 Banking and Finance

Vinge has advised Marginalen Bank Bankaktiebolag (publ) regarding a change of issuer for its outstanding capital notes, consisting of SEK 560 million in Tier 2 Capital Notes and SEK 200 million Additional Tier 1 Capital Notes. ESCO Marginalen AB (publ) will assume all obligations under the existing capital notes in connection with the transaction, while Marginalen Bank issues new capital notes in a corresponding amount by way of set-off.

Vinge assisted with the application for approval of the issuer substitution with the Swedish Financial Supervisory Authority (Sw. Finansinspektionen), as well as with obtaining the consent of the noteholders through written procedures and coordination with Nasdaq regarding the continued admission to trading of the existing capital notes on Nasdaq Stockholm.

ABG Sundal Collier acted as the financial advisor for the transaction.

Vinge’s team consisted of Mikael Ståhl, Arvid Weimers, Henrik Schön, Katja Häglund and Julia Gudmundsson.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025